174 related articles for article (PubMed ID: 2447679)
21. Expression and immunogenicity of HLA-B27 in high-transfection recipient P815: a new method to induce monoclonal antibodies directed against HLA-B27.
Thurau SR; Wildner G; Kuon W; Weiss EH; Riethmüller G
Tissue Antigens; 1989 May; 33(5):511-9. PubMed ID: 2508265
[TBL] [Abstract][Full Text] [Related]
22. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae.
Archer JR
Ann Rheum Dis; 1981 Aug; 40(4):400-3. PubMed ID: 7020615
[TBL] [Abstract][Full Text] [Related]
23. Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella pneumoniae.
Ogasawara M; Kono DH; Yu DT
Infect Immun; 1986 Mar; 51(3):901-8. PubMed ID: 3512439
[TBL] [Abstract][Full Text] [Related]
24. A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA-B44(12) and -B45(12).
Ge J; Bratlie A; Hannestad K
Tissue Antigens; 1992 May; 39(5):258-61. PubMed ID: 1384167
[TBL] [Abstract][Full Text] [Related]
25. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
[TBL] [Abstract][Full Text] [Related]
26. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
Darke C
Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
[TBL] [Abstract][Full Text] [Related]
27. Characterization of two human IgM monoclonal antibodies reactive with HLA-B27.
Wölpl A; Toubert A; Siemoneit K; Eiermann TH; Neumayer H; Goldmann SF
Tissue Antigens; 1995 Oct; 46(4):305-12. PubMed ID: 8560449
[TBL] [Abstract][Full Text] [Related]
28. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
Aparicio P; Vega MA; López de Castro JA
J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
[TBL] [Abstract][Full Text] [Related]
29. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27.
Chen JH; Kono DH; Yong Z; Park MS; Oldstone MM; Yu DT
J Immunol; 1987 Nov; 139(9):3003-11. PubMed ID: 2444647
[TBL] [Abstract][Full Text] [Related]
30. A cytotoxic anti-HLA-AB monoclonal antibody which in dilution becomes specific to HLA-A3 crossreacting group.
Mazzilli MC; Cascino I; Porrini SC; Lavaggi MV; Lulli P; Morellini M; Testa L; Gandini E
Tissue Antigens; 1984 Aug; 24(2):107-12. PubMed ID: 6208633
[TBL] [Abstract][Full Text] [Related]
31. Anti-HLA-B27 antibodies in sera from patients with gram-negative bacterial infections.
Cavender D; Ziff M
Arthritis Rheum; 1986 Mar; 29(3):352-7. PubMed ID: 2421739
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
33. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
McMichael AJ; Gotch FM; Rothbard J
J Exp Med; 1986 Nov; 164(5):1397-406. PubMed ID: 2430041
[TBL] [Abstract][Full Text] [Related]
34. Klebsiella 'modifying factor': binding studies with HLA-B27+ and B27- lymphocytes.
Trapani JA; McKenzie IF
Ann Rheum Dis; 1985 Mar; 44(3):169-75. PubMed ID: 2579614
[TBL] [Abstract][Full Text] [Related]
35. Anti-HLA-A2 and -A28 monoclonal antibody: production and study of the cross-reaction.
Bourel D; Fauchet R; Chevrinais AM; Dejour G; Merdrignac G; Genetet B
Tissue Antigens; 1984 May; 23(5):274-9. PubMed ID: 6611605
[TBL] [Abstract][Full Text] [Related]
36. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody against an epitope common to HLA-b locus antigens.
Billing R; Lucero K
Hum Immunol; 1982 Jul; 4(4):351-7. PubMed ID: 6181038
[TBL] [Abstract][Full Text] [Related]
38. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
Neumüller J; Schwartz DW; Dauber E; Mayr WR
Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
[TBL] [Abstract][Full Text] [Related]
40. Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27.
Yang YH; Grumet FC; Fendly B; Engleman E; Shively JE
Hybridoma; 1982; 1(3):243-55. PubMed ID: 6208127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
